Treatment Indications: correction of deep wrinkles and severe folds (nasolabial folds, marionette lines, deep glabellar and forehead creases);, volumization of cheeks, cheekbones, chin, jawline, and temporal region;, non‑surgical rhinoplasty and nasal ridge refinement;, facial contouring, oval redefinition, and asymmetry correction;, pronounced lifting effect and restoration of significant volume loss;, scar correction
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: deep dermal, subdermal, and supraperiosteal injection for restoration of major volume deficits, structural contouring, and deep fold correction;, densest monophasic gel in the Tesoro line utilizing proprietary DCL (Dual Cross‑Linking) technology with two‑stage cross‑linking and four‑stage purification for maximum viscosity, high cohesivity, and stable shape retention;, providing pronounced lifting effect, even tissue integration without fibrosis formation, and minimal migration (effect duration ~12–24 months)